Butyrate remodels the immune-epigenetic-gut-lung axis: Emerging mechanisms and therapeutic perspectives in asthma
Seminars in Immunopathology · 06.04.2026 · 48 (1)
DOI: 10.1007/s00281-026-01069-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, online erschienen am 06.04.2026. Verfasst von Yuqia Xie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shunde Woman and Children's Hospital of Guangdong Medical University, College of Medical Technology, Guangdong Medical University, Dongguan, 523808, …. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Asthma, Butyrates, Lung. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 122 Literaturangaben.
Abstract (Originalsprache)
Butyrate, a major microbial metabolite derived from dietary fiber fermentation, has emerged as a key regulator in the pathogenesis and treatment of asthma. It modulates the functions of dendritic cells, macrophages, and T cells, thereby reshaping the inflammatory microenvironment. In parallel, butyrate influences the transcriptional activity of inflammation-related genes through epigenetic mechanisms such as histone acetylation, DNA demethylation, and miRNA regulation. Notably, butyrate mediates long-range immune modulation via the gut-lung axis, linking intestinal microbial homeostasis to pulmonary inflammation. This review summarizes current advances in understanding the central role of butyrate within the immune-epigenetic-gut-lung network and discusses emerging therapeutic strategies based on microbiota modulation and targeted delivery systems. Regulation of the butyrate pathway offers new insights into the complex pathogenesis of asthma and potential avenues for innovative therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shunde Woman and Children's Hospital of Guangdong Medical University, College of Medical Technology, Guangdong Medical University, Dongguan, 523808, China.
- Dongguan Key Laboratory of Immunoregulation and Prevention of Pulmonary Diseases, Liaobu Hospital of Dongguan City, Dongguan, 523430, China.
- Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Guangdong Medical University, Dongguan, 523808, China.
- Dongguan Key Laboratory of Immunoregulation and Prevention of Pulmonary Diseases, Liaobu Hospital of Dongguan City, Dongguan, 523430, China. 343430543@qq.com.
- Shunde Woman and Children's Hospital of Guangdong Medical University, College of Medical Technology, Guangdong Medical University, Dongguan, 523808, China. ouyangsd@gdmu.edu.cn.
- Dongguan Key Laboratory of Immunoregulation and Prevention of Pulmonary Diseases, Liaobu Hospital of Dongguan City, Dongguan, 523430, China. ouyangsd@gdmu.edu.cn.
Zitieren
APA
Xie, Y., Huang, G., Zhao, J., Yuan, Z., Li, H., Deng, J., Chen, D., Zhu, W., Huang, G., Li, Y., & Ouyang, S. (2026). Butyrate remodels the immune-epigenetic-gut-lung axis: Emerging mechanisms and therapeutic perspectives in asthma. Seminars in Immunopathology, 48(1). https://doi.org/10.1007/s00281-026-01069-w
Vancouver
Xie Y, Huang G, Zhao J, Yuan Z, Li H, Deng J, et al. Butyrate remodels the immune-epigenetic-gut-lung axis: Emerging mechanisms and therapeutic perspectives in asthma. Seminars in Immunopathology. 2026;48(1). doi:10.1007/s00281-026-01069-w
BibTeX
@article{Xie2026,
author = {Xie, Yuqia and Huang, Guochun and Zhao, Jun and Yuan, Zhicheng and Li, Hangyu and Deng, Jingyi and Chen, Daichi and Zhu, Wenlu and Huang, Gonghua and Li, Yuanhui and Ouyang, Suidong},
title = {Butyrate remodels the immune-epigenetic-gut-lung axis: Emerging mechanisms and therapeutic perspectives in asthma},
journal = {Seminars in Immunopathology},
year = {2026},
volume = {48},
number = {1},
doi = {10.1007/s00281-026-01069-w}
}
EUVIMED